|
N-methyl-3-[3-(trifluoromethyl)-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]benzamide |
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Cusumano CK, et al. 2011. Sci Transl Med |
|
N-methyl-3-[3-methyl-4-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]benzamide |
Depiction based on curated SMILES
H
H
H
H
H
O
HO
OH
OH
OH
CH
3
O
NH
CH
3
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
N-methyl-3-[4-[[(2R,3S,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]methyl]phenyl]benzamide |
Depiction based on curated SMILES
OH
OH
HO
HO
H
3
C
O
O
NH
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
[3,4,5-triacetyloxy-6-[(R)-acetyloxy-(4-bromo-2-methylphenyl)methyl]oxan-2-yl]methyl acetate |
Depiction based on curated SMILES
O
Br
O
CH
3
O
CH
3
O
O
CH
3
O
H
O
O
O
H
3
C
O
CH
3
O
H
3
C
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
[3,4,5-triacetyloxy-6-[2-methyl-4-[3-(methylcarbamoyl)phenyl]phenoxy]oxan-2-yl]methyl acetate |
Depiction based on curated SMILES
O
O
CH
3
O
O
CH
3
O
CH
3
O
CH
3
NH
O
H
3
C
O
O
O
CH
3
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
[3,4,5-trihydroxy-6-[2-methyl-4-[3-(methylcarbamoyl)phenyl]phenoxy]oxan-2-yl]methyl 2-(dimethylamino)acetate |
Depiction based on curated SMILES
OH
O
N
CH
3
CH
3
HO
OH
CH
3
N
H
O
H
3
C
O
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
[3,4,5-trihydroxy-6-[2-methyl-4-[3-(methylcarbamoyl)phenyl]phenoxy]oxan-2-yl]methyl dihydrogen phosphate |
Depiction based on curated SMILES
P
O
OH
HO
HO
OH
O
OH
CH
3
H
3
C
O
O
O
N
H
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Compound 19R (internal name in literature) |
Depiction based on curated SMILES
O
O
Br
OH
O
CH
3
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Compound 26 (internal name in literature) |
Depiction based on curated SMILES
O
O
O
O
O
H
CH
3
Br
CH
3
O
O
|
Escherichia |
Type 1 fimbriae |
Preclinical (in vivo) |
Mydock-McGrane L, et al. 2016. J Med Chem |
|
Maprotiline |
Depiction based on curated SMILES
H
3
C
N
H
|
Francisella |
Regulation |
Preclinical (in vivo) |
Dean SN, et al. 2015. Virulence |
|
| | |